# Oncolytics Biotech Inc: Form 6-K, filed Oct 20, 2025

- Company: [Oncolytics Biotech Inc](/companies/oncy.md) (CIK 1129928)
- Form: 6-K
- Filed: 2025-10-20
- Accepted by EDGAR: Oct 17, 2025, 21:54 ET
- Period: 2025-10-17
- Accession: 0001104659-25-100535
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1129928/000110465925100535/tm2528875d1_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1129928/000110465925100535/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1129928/000110465925100535/tm2528875d1_6k.htm

Filed Oct 20, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-100535. Last ingested by Listed: Nov 4, 2026, 09:43 ET. No prices; not investment advice.